Moreover, in a study on early diabetic nephropathy patients receiving CaD for 12 weeks, Dong et al. [33] detected decreased serum levels of endothelin-1 and increased levels of nitric oxide, which in turn led to a delay in the development of diabetic nephropathy. The gene discussed is EDN1; the disease is diabetic kidney disease.